news

How does the desire to "want to use it again" arise? Exploring the process of becoming addicted to lip balm through continued use.

Tackling the cleansing challenge with pure vitamin C. Verifying the effects of vitamin C and developing new cleansing formulation technology.

Rohto Pharmaceutical Co., Ltd. holds "Phytoexosome Research Meeting"

ROHTO V5 Vision Power New Release

Rohto Pharmaceutical, Rohto Wellcoat, and Nissui have collaborated for the first time. The "Brilloth Donburi" is born, a dish that encourages health through "eating fish."

Presented at the 36th IFSCC World Congress: Discovery of a new moisturizing function in phytoexosomes utilizing sake fermentation technology.

Presented at the 36th IFSCC World Congress. Research toward the construction of a stimulus perception evaluation system using a three-dimensional cultured skin model incorporating iPS cell-derived sensory nerve cells.

Presented at the 36th IFSCC World Congress. Focusing on the structure of the cream film after application to the skin, we have elucidated a part of the mechanism by which moisture is retained.

Selected as one of the Top 10 oral presentations at the 36th IFSCC World Congress. The presentation suggested a new possibility: "Maintaining soft skin" can guide aging cells back to a youthful state.

Rohto Pharmaceutical and Taiyo Life's Institute for Research on Aging Society Conduct their first joint survey. Approximately 60-70% of parents are conscious of their children's eye health.

Regarding the conclusion of an exclusive domestic distribution agreement with PharmaBio Co., Ltd. for "PAL-222," a Regenerative medicine product currently under development for myopic chorioretinal atrophy.

Cordyceps sinensis, a traditional medicinal ingredient, is suggested to activate neural circuit formation and energy metabolism in the brain.

"THE THE LYPO," a beauty supplement containing two types of vitamin C—sustained-release and fast-acting—has been renewed.

Phase II investigator-initiated clinical trial of RE-01 cell therapy for refractory ischemic (non-arteriosclerotic) lower extremity ulcers caused by Buerger's disease and collagen diseases initiated.

The key to azelaic acid lies in "how it's dissolved." A low-irritation serum formulation demonstrating acne-fighting efficacy comparable to a 20% cream has been established.

Rohto Pharmaceutical has published the "ROHTO Well-being Report - Integrated Report 2026".

Announcement Regarding the Acquisition of OP Biofactory as a Subsidiary

Supporting the establishment of the "General Incorporated Association for the Study of Ectopic Fat."

Azelaic acid is now available in a serum that makes it easy to incorporate into your daily skincare routine. "AZA Clear® Serum" is now available from the medical institution-exclusive brand "DRX®".

Rohto Pharmaceutical's "Mokatsu® Project" is participating.

Regarding the status of the investigation into unauthorized access to our systems

Regarding the possibility of unauthorized access to our system

Announcement of the publication of "Rohto Health White Paper 2026"

Notice Regarding Voluntary Recall of Vietnamese-Made Eye Drops in the United States

Regarding support for the 2026 Kumamoto Earthquake

Rohto launches "Rohto Medical Eye," a website for healthcare professionals.

Regarding the issue of the old DRX brand website URL being redirected to a fraudulent site.

Initiatives to Ensure Safety in Cell Therapy

Notice of changes to packaging specifications due to environmental considerations

Publication of "Rohto Health White Paper 2025"

Please purchase from authorized Obagi retailers.

Initiatives to Ensure Safety in Cell Therapy

Setting new health and productivity management indicators for 2030

Report and Apology Regarding the Consumer Affairs Agency's Corrective Order

Revision of the "Multi-Stakeholder Policy"

Report and Apology Regarding the Consumer Affairs Agency's Corrective Order

Rohto Group formulates "Basic Policy on Customer Harassment"

Please be careful of suspicious investment solicitations related to our company.

Beware of counterfeit "Lush Rich" products

Please be aware of suspicious e-mails purporting to be from our company's employees and directors

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

We are pleased to announce the recipients of the 20th Rohto Prize, a research fund specializing in "Japanese Association of Geriatric Dermatology Research Fund skin."

The recipients of the 17th Rohto Women's Health Science Research Award have been decided.

The winners of the 31st ROHTO AWARD research grants have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

We are pleased to announce the 19th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

The 16th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 30th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

We are pleased to announce the 18th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

The 4th Rohto Regenerative medicine Forum was held

The 15th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 29th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

We are pleased to announce the 17th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

The 3rd Rohto Regenerative medicine Forum was held

The 14th recipients of the Rohto Women's Health Science Research Award have been announced